Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2026(Status and Outlook)
Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.First, the market demand for NIPS is growing. With the improvement of people"s health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.
The global Non-Invasive Prenatal Screening (NIPS) market size was estimated at USD 4524.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-Invasive Prenatal Screening (NIPS) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-Invasive Prenatal Screening (NIPS) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-Invasive Prenatal Screening (NIPS) market.
Global Non-Invasive Prenatal Screening (NIPS) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market Segmentation (by Type)
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-Invasive Prenatal Screening (NIPS) Market
Overview of the regional outlook of the Non-Invasive Prenatal Screening (NIPS) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Prenatal Screening (NIPS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-Invasive Prenatal Screening (NIPS), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Non-Invasive Prenatal Screening (NIPS) market size was estimated at USD 4524.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-Invasive Prenatal Screening (NIPS) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-Invasive Prenatal Screening (NIPS) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-Invasive Prenatal Screening (NIPS) market.
Global Non-Invasive Prenatal Screening (NIPS) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Myriad Genetics
Illumina
Progenity
Natera
Yourgene Health
Roche Sequencing Solutions (RSS)
Eurofins LifeCodexx GmbH
Labcorp
PerkinElmer
Harmony
Market Segmentation (by Type)
Trisomy 21
Trisomy 18
Trisomy 13
Sex Chromosome Aneuploidies
Others
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-Invasive Prenatal Screening (NIPS) Market
Overview of the regional outlook of the Non-Invasive Prenatal Screening (NIPS) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Prenatal Screening (NIPS) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-Invasive Prenatal Screening (NIPS), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-Invasive Prenatal Screening (NIPS)
1.2 Key Market Segments
1.2.1 Non-Invasive Prenatal Screening (NIPS) Segment by Type
1.2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-Invasive Prenatal Screening (NIPS) Product Life Cycle
3.3 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2020-2025)
3.4 Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Non-Invasive Prenatal Screening (NIPS) Market Competitive Situation and Trends
3.6.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) VALUE CHAIN ANALYSIS
4.1 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-Invasive Prenatal Screening (NIPS) Market Porter's Five Forces Analysis
6 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Prenatal Screening (NIPS) Market by Type (2020-2025)
6.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
7 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Application (2020-2025)
7.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
8 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Myriad Genetics
9.1.1 Myriad Genetics Basic Information
9.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
9.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.1.4 Myriad Genetics SWOT Analysis
9.1.5 Myriad Genetics Business Overview
9.1.6 Myriad Genetics Recent Developments
9.2 Illumina
9.2.1 Illumina Basic Information
9.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
9.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.2.4 Illumina SWOT Analysis
9.2.5 Illumina Business Overview
9.2.6 Illumina Recent Developments
9.3 Progenity
9.3.1 Progenity Basic Information
9.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
9.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.3.4 Progenity SWOT Analysis
9.3.5 Progenity Business Overview
9.3.6 Progenity Recent Developments
9.4 Natera
9.4.1 Natera Basic Information
9.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
9.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.4.4 Natera Business Overview
9.4.5 Natera Recent Developments
9.5 Yourgene Health
9.5.1 Yourgene Health Basic Information
9.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
9.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.5.4 Yourgene Health Business Overview
9.5.5 Yourgene Health Recent Developments
9.6 Roche Sequencing Solutions (RSS)
9.6.1 Roche Sequencing Solutions (RSS) Basic Information
9.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
9.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.6.4 Roche Sequencing Solutions (RSS) Business Overview
9.6.5 Roche Sequencing Solutions (RSS) Recent Developments
9.7 Eurofins LifeCodexx GmbH
9.7.1 Eurofins LifeCodexx GmbH Basic Information
9.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
9.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.7.4 Eurofins LifeCodexx GmbH Business Overview
9.7.5 Eurofins LifeCodexx GmbH Recent Developments
9.8 Labcorp
9.8.1 Labcorp Basic Information
9.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
9.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.8.4 Labcorp Business Overview
9.8.5 Labcorp Recent Developments
9.9 PerkinElmer
9.9.1 PerkinElmer Basic Information
9.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
9.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.9.4 PerkinElmer Business Overview
9.9.5 PerkinElmer Recent Developments
9.10 Harmony
9.10.1 Harmony Basic Information
9.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
9.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.10.4 Harmony Business Overview
9.10.5 Harmony Recent Developments
10 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET FORECAST BY REGION
10.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast
10.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region
10.2.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Non-Invasive Prenatal Screening (NIPS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2026-2035)
11.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2026-2035)
11.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2026-2035)
11.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-Invasive Prenatal Screening (NIPS)
1.2 Key Market Segments
1.2.1 Non-Invasive Prenatal Screening (NIPS) Segment by Type
1.2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-Invasive Prenatal Screening (NIPS) Product Life Cycle
3.3 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Company (2020-2025)
3.4 Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Non-Invasive Prenatal Screening (NIPS) Market Competitive Situation and Trends
3.6.1 Non-Invasive Prenatal Screening (NIPS) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Invasive Prenatal Screening (NIPS) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NON-INVASIVE PRENATAL SCREENING (NIPS) VALUE CHAIN ANALYSIS
4.1 Non-Invasive Prenatal Screening (NIPS) Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-Invasive Prenatal Screening (NIPS) Market Porter's Five Forces Analysis
6 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Prenatal Screening (NIPS) Market by Type (2020-2025)
6.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
7 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Application (2020-2025)
7.3 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
8 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET SEGMENTATION BY REGION
8.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.1.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Myriad Genetics
9.1.1 Myriad Genetics Basic Information
9.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
9.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.1.4 Myriad Genetics SWOT Analysis
9.1.5 Myriad Genetics Business Overview
9.1.6 Myriad Genetics Recent Developments
9.2 Illumina
9.2.1 Illumina Basic Information
9.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
9.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.2.4 Illumina SWOT Analysis
9.2.5 Illumina Business Overview
9.2.6 Illumina Recent Developments
9.3 Progenity
9.3.1 Progenity Basic Information
9.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
9.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.3.4 Progenity SWOT Analysis
9.3.5 Progenity Business Overview
9.3.6 Progenity Recent Developments
9.4 Natera
9.4.1 Natera Basic Information
9.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
9.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.4.4 Natera Business Overview
9.4.5 Natera Recent Developments
9.5 Yourgene Health
9.5.1 Yourgene Health Basic Information
9.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
9.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.5.4 Yourgene Health Business Overview
9.5.5 Yourgene Health Recent Developments
9.6 Roche Sequencing Solutions (RSS)
9.6.1 Roche Sequencing Solutions (RSS) Basic Information
9.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
9.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.6.4 Roche Sequencing Solutions (RSS) Business Overview
9.6.5 Roche Sequencing Solutions (RSS) Recent Developments
9.7 Eurofins LifeCodexx GmbH
9.7.1 Eurofins LifeCodexx GmbH Basic Information
9.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
9.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.7.4 Eurofins LifeCodexx GmbH Business Overview
9.7.5 Eurofins LifeCodexx GmbH Recent Developments
9.8 Labcorp
9.8.1 Labcorp Basic Information
9.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
9.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.8.4 Labcorp Business Overview
9.8.5 Labcorp Recent Developments
9.9 PerkinElmer
9.9.1 PerkinElmer Basic Information
9.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
9.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.9.4 PerkinElmer Business Overview
9.9.5 PerkinElmer Recent Developments
9.10 Harmony
9.10.1 Harmony Basic Information
9.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
9.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Product Market Performance
9.10.4 Harmony Business Overview
9.10.5 Harmony Recent Developments
10 NON-INVASIVE PRENATAL SCREENING (NIPS) MARKET FORECAST BY REGION
10.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast
10.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region
10.2.4 South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Non-Invasive Prenatal Screening (NIPS) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Type (2026-2035)
11.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2026-2035)
11.2 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast by Application (2026-2035)
11.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 5. Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Region (M USD)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) by Company (2020-2025)
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Non-Invasive Prenatal Screening (NIPS) Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Non-Invasive Prenatal Screening (NIPS) Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Type (2020-2025)
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2020-2025)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2020-2025) & (M USD)
Table 27. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2020-2025)
Table 28. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
Table 29. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2020-2025)
Table 31. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 34. South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 36. Myriad Genetics Basic Information
Table 37. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 38. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Myriad Genetics SWOT Analysis
Table 40. Myriad Genetics Business Overview
Table 41. Myriad Genetics Recent Developments
Table 42. Illumina Basic Information
Table 43. Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 44. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Illumina SWOT Analysis
Table 46. Illumina Business Overview
Table 47. Illumina Recent Developments
Table 48. Progenity Basic Information
Table 49. Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 50. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Progenity SWOT Analysis
Table 52. Progenity Business Overview
Table 53. Progenity Recent Developments
Table 54. Natera Basic Information
Table 55. Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 56. Natera Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Natera Business Overview
Table 58. Natera Recent Developments
Table 59. Yourgene Health Basic Information
Table 60. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 61. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Yourgene Health Business Overview
Table 63. Yourgene Health Recent Developments
Table 64. Roche Sequencing Solutions (RSS) Basic Information
Table 65. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 66. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Roche Sequencing Solutions (RSS) Business Overview
Table 68. Roche Sequencing Solutions (RSS) Recent Developments
Table 69. Eurofins LifeCodexx GmbH Basic Information
Table 70. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 71. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Eurofins LifeCodexx GmbH Business Overview
Table 73. Eurofins LifeCodexx GmbH Recent Developments
Table 74. Labcorp Basic Information
Table 75. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 76. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Labcorp Business Overview
Table 78. Labcorp Recent Developments
Table 79. PerkinElmer Basic Information
Table 80. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 81. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 82. PerkinElmer Business Overview
Table 83. PerkinElmer Recent Developments
Table 84. Harmony Basic Information
Table 85. Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 86. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Harmony Business Overview
Table 88. Harmony Recent Developments
Table 89. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 5. Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Region (M USD)
Table 6. Global Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) by Company (2020-2025)
Table 7. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Non-Invasive Prenatal Screening (NIPS) Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Non-Invasive Prenatal Screening (NIPS) Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (M USD)
Table 22. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) by Type (2020-2025)
Table 23. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type (2020-2025)
Table 24. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
Table 25. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application
Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2020-2025) & (M USD)
Table 27. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2020-2025)
Table 28. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
Table 29. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2020-2025)
Table 31. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 34. South America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (M USD)
Table 36. Myriad Genetics Basic Information
Table 37. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 38. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Myriad Genetics SWOT Analysis
Table 40. Myriad Genetics Business Overview
Table 41. Myriad Genetics Recent Developments
Table 42. Illumina Basic Information
Table 43. Illumina Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 44. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Illumina SWOT Analysis
Table 46. Illumina Business Overview
Table 47. Illumina Recent Developments
Table 48. Progenity Basic Information
Table 49. Progenity Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 50. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Progenity SWOT Analysis
Table 52. Progenity Business Overview
Table 53. Progenity Recent Developments
Table 54. Natera Basic Information
Table 55. Natera Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 56. Natera Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Natera Business Overview
Table 58. Natera Recent Developments
Table 59. Yourgene Health Basic Information
Table 60. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 61. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 62. Yourgene Health Business Overview
Table 63. Yourgene Health Recent Developments
Table 64. Roche Sequencing Solutions (RSS) Basic Information
Table 65. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 66. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Roche Sequencing Solutions (RSS) Business Overview
Table 68. Roche Sequencing Solutions (RSS) Recent Developments
Table 69. Eurofins LifeCodexx GmbH Basic Information
Table 70. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 71. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Eurofins LifeCodexx GmbH Business Overview
Table 73. Eurofins LifeCodexx GmbH Recent Developments
Table 74. Labcorp Basic Information
Table 75. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 76. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Labcorp Business Overview
Table 78. Labcorp Recent Developments
Table 79. PerkinElmer Basic Information
Table 80. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 81. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 82. PerkinElmer Business Overview
Table 83. PerkinElmer Recent Developments
Table 84. Harmony Basic Information
Table 85. Harmony Non-Invasive Prenatal Screening (NIPS) Product Overview
Table 86. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Harmony Business Overview
Table 88. Harmony Recent Developments
Table 89. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Non-Invasive Prenatal Screening (NIPS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD), 2025-2035
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Non-Invasive Prenatal Screening (NIPS) Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Product Life Cycle
Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company in 2025
Figure 13. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2025
Figure 15. Value Chain Map of Non-Invasive Prenatal Screening (NIPS)
Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market PEST Analysis
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type
Figure 20. Market Share of Non-Invasive Prenatal Screening (NIPS) by Type (2020-2025)
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application
Figure 24. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2020-2025)
Figure 25. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application in 2024
Figure 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2020-2025)
Figure 28. North America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2024
Figure 30. U.S. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country in 2024
Figure 35. Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2024
Figure 42. China Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 48. South America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2024
Figure 49. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2026-2035)
Figure 61. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Non-Invasive Prenatal Screening (NIPS)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD), 2025-2035
Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Non-Invasive Prenatal Screening (NIPS) Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Product Life Cycle
Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Revenue Share by Company in 2025
Figure 13. Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2025
Figure 15. Value Chain Map of Non-Invasive Prenatal Screening (NIPS)
Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market PEST Analysis
Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type
Figure 20. Market Share of Non-Invasive Prenatal Screening (NIPS) by Type (2020-2025)
Figure 21. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application
Figure 24. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application (2020-2025)
Figure 25. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application in 2024
Figure 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2020-2025)
Figure 28. North America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2024
Figure 30. U.S. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country in 2024
Figure 35. Germany Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2024
Figure 42. China Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 48. South America Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2024
Figure 49. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Type (2026-2035)
Figure 61. Global Non-Invasive Prenatal Screening (NIPS) Market Share Forecast by Application (2026-2035)
